| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0074-7742(10)90017-2 |
| P8608 | Fatcat ID | release_fna5jyzpurewjag3e5y2o7o5by |
| P698 | PubMed publication ID | 20692506 |
| P50 | author | Jens Eyding | Q86797657 |
| P2093 | author name string | Christos Krogias | |
| Thomas Postert | |||
| P2860 | cites work | An Inventory for Measuring Depression | Q26778503 |
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation | Q28246858 | ||
| Huntington's disease | Q28284355 | ||
| Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles | Q28589989 | ||
| Development of a Rating Scale for Primary Depressive Illness | Q29616244 | ||
| Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography | Q30495614 | ||
| Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings | Q30651550 | ||
| Transcranial brain parenchyma sonography in movement disorders: state of the art. | Q31088283 | ||
| Neural bases of dysphoria in early Huntington's disease | Q31139428 | ||
| Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury | Q33183795 | ||
| Transcranial sonography in movement disorders | Q33378406 | ||
| Functional imaging in Huntington's disease | Q33403110 | ||
| Mental health and quality of life after genetic testing for Huntington disease: A long-term effect study in Germany | Q60450609 | ||
| Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging | Q64797293 | ||
| Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study | Q71787756 | ||
| Evaluation of the ventricular system in adults by transcranial duplex sonography | Q72160305 | ||
| Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes | Q95395009 | ||
| PET and movement disorders | Q33631701 | ||
| Juvenile onset Huntington's disease--clinical and research perspectives. | Q34091006 | ||
| Long-term outcome of presymptomatic testing in Huntington disease | Q34325599 | ||
| Loss of disgust. Perception of faces and emotions in Huntington's disease | Q34408294 | ||
| Subtle changes among presymptomatic carriers of the Huntington's disease gene | Q35460244 | ||
| Neuropsychiatric aspects of Huntington's disease. | Q35463916 | ||
| Autonomic nervous system function in Huntington's disease. | Q35467961 | ||
| Psychiatric disorders in preclinical Huntington's disease | Q36227490 | ||
| Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment. | Q36237095 | ||
| Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers | Q36317837 | ||
| Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset | Q37073913 | ||
| Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity | Q37132239 | ||
| The current clinical management of Huntington's disease | Q37200714 | ||
| Profile of cognitive progression in early Huntington's disease. | Q38424620 | ||
| Onset and rate of striatal atrophy in preclinical Huntington disease | Q40496996 | ||
| Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis | Q40585913 | ||
| NMDA receptor losses in putamen from patients with Huntington's disease | Q41336261 | ||
| In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease | Q42468402 | ||
| Huntington's disease as caused by 34 CAG repeats. | Q45288830 | ||
| Risk factors for suicide in Huntingtons disease: a retrospective case controlled study | Q45289926 | ||
| Locus coeruleus involvement in Huntington's disease | Q45291838 | ||
| Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease | Q45292176 | ||
| Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease | Q45293293 | ||
| Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis | Q45294953 | ||
| Validation of self-report depression rating scales in Huntington's disease | Q45295854 | ||
| Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. | Q45298559 | ||
| Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography | Q45299145 | ||
| Bradykinesia in early Huntington's disease | Q45299737 | ||
| The association of CAG repeat length with clinical progression in Huntington disease | Q45300690 | ||
| Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan | Q45304491 | ||
| Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study | Q45305040 | ||
| Differential Perceptual-Spatial Impairment in Huntington's and Alzheimer's Dementias | Q45305399 | ||
| Morphology of the cerebral cortex in preclinical Huntington's disease. | Q45306087 | ||
| Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year | Q45306639 | ||
| Vulnerability of the nigrostriatal system as detected by transcranial ultrasound | Q48106731 | ||
| Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia | Q48138851 | ||
| Relationship of brainstem raphe echogenicity and clinical findings in depressive states | Q48225983 | ||
| The validity of criteria for the evaluation of cerebral atrophy by computed tomography | Q48453406 | ||
| Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter | Q48769629 | ||
| Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy | Q48786342 | ||
| Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography | Q48881690 | ||
| Relationship of substantia nigra echogenicity and motor function in elderly subjects | Q49102040 | ||
| Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. | Q50280074 | ||
| Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. | Q53615051 | ||
| Unified Huntington's disease rating scale: Reliability and consistency | Q57422462 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 237-257 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | International Review of Neurobiology | Q15754273 |
| P1476 | title | Transcranial sonography in Huntington's disease | |
| Transcranial Sonography in Huntington’S Disease | |||
| P478 | volume | 90 |
| Q48397754 | A population-based study on combined markers for early Parkinson's disease |
| Q64786292 | Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis |
| Q89898163 | Diagnostic Performance of Transcranial Sonography for Evaluating Substantia Nigra Hyper-echogenicity in Patients with Parkinson's Disease |
| Q45303272 | Echogenicity of basal ganglia structures in different Huntington's disease phenotypes |
| Q48178005 | Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography |
| Q48070501 | Hypoechogenicity of brainstem raphe nuclei is associated with increased attack frequency in episodic migraine |
| Q92152711 | Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology |
| Q33917085 | Milestones in magnetic resonance imaging and transcranial sonography of movement disorders |
| Q38818865 | Transcranial Sonography Findings in Depression in Association With Psychiatric and Neurologic Diseases: A Review. |
| Q47986869 | Transcranial Sonography in Neurodegenerative Diseases with Cognitive Decline |
Search more.